Sirna Therapeutics said this week that it has formed a sponsored-research collaboration with Massachusetts General Hospital researcher Zheng-Yi Chen to support his work into using RNA interference to restore hearing loss.
Chen's research focuses on the gene expressing retinoblastoma protein, pRb. According to Chen, this gene has been found to play a role in the production of hair cells in the inner ear, which convert sound into neural impulses.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
